VHIO´s Clinical Research Program directed by Josep Tabernero, will continue to incorporate the following groups:
Breast Cancer and Melanoma led by Javier Cortes, Head, Neck and Gynecological Tumors headed by Josep Maria del Campo, Josep Tabernero´s Gastrointestinal Tumor Group, Genitourinary, CNS Tumors, Sarcoma and Cancer of Unknown Primary Site Program Group directed by Joan Carles, Enriqueta Felip’s Thoracic Tumor Group, Radiation Oncology under Jordi Giralt´s leadership, High Risk and Cancer Prevention Group led by Judith BalmaÃ±a, Hematology Oncology headed by Francesc Bosch, and Oncogenetics Group led by Orland DÃez.
VHIO´S clinical research activity continues to be supported by essential core services including the Clinical Trials Office whose activities are headed by Irene Marimon, Gemma Sala and Susana MuÃ±oz, the Clinical Research Nurse Unit supervised by Nines PeÃ±uelas, and the Oncology Pharmaceutical Care Program Unit led by Maria-Josep Carreras Soler and Laura MaÃ±Ã³s Pujol, as well as database and statistical management.
To deliver on the necessary expansion ahead, this Program will also extend its research through the future incorporation of new groups.
VHIO: Working together to advance personalized and targeted therapies against cancer